Neuropathic Pain Management Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: N0FAF2458067EN
Market Monitor Global

Abstracts

Neuropathic pain management refers to a way to relieve and treat neuropathic pain through various drugs or treatments.

This report contains market size and forecasts of Neuropathic Pain Management in Global, including the following market information:

Global Neuropathic Pain Management Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neuropathic Pain Management market was valued at 8773.9 million in 2021 and is projected to reach US$ 10860 million by 2028, at a CAGR of 3.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tricyclic Antidepressant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neuropathic Pain Management include Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation and Depomed. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuropathic Pain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neuropathic Pain Management Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neuropathic Pain Management Market Segment Percentages, by Type, 2021 (%)

• Tricyclic Antidepressant
• Anticonvulsant
• Opioid
• Steroid Drug
• Local Anesthesia
• Other

Global Neuropathic Pain Management Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neuropathic Pain Management Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacy
• Hospital Pharmacy
• Other

Global Neuropathic Pain Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neuropathic Pain Management Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neuropathic Pain Management revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neuropathic Pain Management revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Johnson & Johnson Services
• Sanofi
• GlaxoSmithKline
• Eli Lilly and Company
• Bristol-Myers Squibb
• Biogen Idec
• Baxter Healthcare Corporation
• Depomed

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neuropathic Pain Management Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neuropathic Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROPATHIC PAIN MANAGEMENT OVERALL MARKET SIZE

2.1 Global Neuropathic Pain Management Market Size: 2021 VS 2028
2.2 Global Neuropathic Pain Management Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neuropathic Pain Management Players in Global Market
3.2 Top Global Neuropathic Pain Management Companies Ranked by Revenue
3.3 Global Neuropathic Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Management Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neuropathic Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Management Players in Global Market
  3.6.1 List of Global Tier 1 Neuropathic Pain Management Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Management Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neuropathic Pain Management Market Size Markets, 2021 & 2028
  4.1.2 Tricyclic Antidepressant
  4.1.3 Anticonvulsant
  4.1.4 Opioid
  4.1.5 Steroid Drug
  4.1.6 Local Anesthesia
  4.1.7 Other
4.2 By Type - Global Neuropathic Pain Management Revenue & Forecasts
  4.2.1 By Type - Global Neuropathic Pain Management Revenue, 2017-2022
  4.2.2 By Type - Global Neuropathic Pain Management Revenue, 2023-2028
  4.2.3 By Type - Global Neuropathic Pain Management Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neuropathic Pain Management Market Size, 2021 & 2028
  5.1.2 Retail Pharmacy
  5.1.3 Hospital Pharmacy
  5.1.4 Other
5.2 By Application - Global Neuropathic Pain Management Revenue & Forecasts
  5.2.1 By Application - Global Neuropathic Pain Management Revenue, 2017-2022
  5.2.2 By Application - Global Neuropathic Pain Management Revenue, 2023-2028
  5.2.3 By Application - Global Neuropathic Pain Management Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neuropathic Pain Management Market Size, 2021 & 2028
6.2 By Region - Global Neuropathic Pain Management Revenue & Forecasts
  6.2.1 By Region - Global Neuropathic Pain Management Revenue, 2017-2022
  6.2.2 By Region - Global Neuropathic Pain Management Revenue, 2023-2028
  6.2.3 By Region - Global Neuropathic Pain Management Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neuropathic Pain Management Revenue, 2017-2028
  6.3.2 US Neuropathic Pain Management Market Size, 2017-2028
  6.3.3 Canada Neuropathic Pain Management Market Size, 2017-2028
  6.3.4 Mexico Neuropathic Pain Management Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neuropathic Pain Management Revenue, 2017-2028
  6.4.2 Germany Neuropathic Pain Management Market Size, 2017-2028
  6.4.3 France Neuropathic Pain Management Market Size, 2017-2028
  6.4.4 U.K. Neuropathic Pain Management Market Size, 2017-2028
  6.4.5 Italy Neuropathic Pain Management Market Size, 2017-2028
  6.4.6 Russia Neuropathic Pain Management Market Size, 2017-2028
  6.4.7 Nordic Countries Neuropathic Pain Management Market Size, 2017-2028
  6.4.8 Benelux Neuropathic Pain Management Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neuropathic Pain Management Revenue, 2017-2028
  6.5.2 China Neuropathic Pain Management Market Size, 2017-2028
  6.5.3 Japan Neuropathic Pain Management Market Size, 2017-2028
  6.5.4 South Korea Neuropathic Pain Management Market Size, 2017-2028
  6.5.5 Southeast Asia Neuropathic Pain Management Market Size, 2017-2028
  6.5.6 India Neuropathic Pain Management Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neuropathic Pain Management Revenue, 2017-2028
  6.6.2 Brazil Neuropathic Pain Management Market Size, 2017-2028
  6.6.3 Argentina Neuropathic Pain Management Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neuropathic Pain Management Revenue, 2017-2028
  6.7.2 Turkey Neuropathic Pain Management Market Size, 2017-2028
  6.7.3 Israel Neuropathic Pain Management Market Size, 2017-2028
  6.7.4 Saudi Arabia Neuropathic Pain Management Market Size, 2017-2028
  6.7.5 UAE Neuropathic Pain Management Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Neuropathic Pain Management Major Product Offerings
  7.1.4 Pfizer Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Johnson & Johnson Services
  7.2.1 Johnson & Johnson Services Corporate Summary
  7.2.2 Johnson & Johnson Services Business Overview
  7.2.3 Johnson & Johnson Services Neuropathic Pain Management Major Product Offerings
  7.2.4 Johnson & Johnson Services Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Services Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Neuropathic Pain Management Major Product Offerings
  7.3.4 Sanofi Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Neuropathic Pain Management Major Product Offerings
  7.4.4 GlaxoSmithKline Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Neuropathic Pain Management Major Product Offerings
  7.5.4 Eli Lilly and Company Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly and Company Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Neuropathic Pain Management Major Product Offerings
  7.6.4 Bristol-Myers Squibb Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Key News
7.7 Biogen Idec
  7.7.1 Biogen Idec Corporate Summary
  7.7.2 Biogen Idec Business Overview
  7.7.3 Biogen Idec Neuropathic Pain Management Major Product Offerings
  7.7.4 Biogen Idec Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.7.5 Biogen Idec Key News
7.8 Baxter Healthcare Corporation
  7.8.1 Baxter Healthcare Corporation Corporate Summary
  7.8.2 Baxter Healthcare Corporation Business Overview
  7.8.3 Baxter Healthcare Corporation Neuropathic Pain Management Major Product Offerings
  7.8.4 Baxter Healthcare Corporation Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.8.5 Baxter Healthcare Corporation Key News
7.9 Depomed
  7.9.1 Depomed Corporate Summary
  7.9.2 Depomed Business Overview
  7.9.3 Depomed Neuropathic Pain Management Major Product Offerings
  7.9.4 Depomed Neuropathic Pain Management Revenue in Global Market (2017-2022)
  7.9.5 Depomed Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neuropathic Pain Management Market Opportunities & Trends in Global Market
Table 2. Neuropathic Pain Management Market Drivers in Global Market
Table 3. Neuropathic Pain Management Market Restraints in Global Market
Table 4. Key Players of Neuropathic Pain Management in Global Market
Table 5. Top Neuropathic Pain Management Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neuropathic Pain Management Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neuropathic Pain Management Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neuropathic Pain Management Product Type
Table 9. List of Global Tier 1 Neuropathic Pain Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuropathic Pain Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neuropathic Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neuropathic Pain Management Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neuropathic Pain Management Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neuropathic Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neuropathic Pain Management Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neuropathic Pain Management Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neuropathic Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neuropathic Pain Management Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neuropathic Pain Management Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neuropathic Pain Management Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neuropathic Pain Management Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neuropathic Pain Management Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neuropathic Pain Management Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neuropathic Pain Management Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neuropathic Pain Management Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neuropathic Pain Management Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neuropathic Pain Management Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neuropathic Pain Management Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neuropathic Pain Management Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Neuropathic Pain Management Product Offerings
Table 32. Pfizer Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Services Corporate Summary
Table 34. Johnson & Johnson Services Neuropathic Pain Management Product Offerings
Table 35. Johnson & Johnson Services Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Neuropathic Pain Management Product Offerings
Table 38. Sanofi Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Neuropathic Pain Management Product Offerings
Table 41. GlaxoSmithKline Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Neuropathic Pain Management Product Offerings
Table 44. Eli Lilly and Company Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Neuropathic Pain Management Product Offerings
Table 47. Bristol-Myers Squibb Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 48. Biogen Idec Corporate Summary
Table 49. Biogen Idec Neuropathic Pain Management Product Offerings
Table 50. Biogen Idec Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 51. Baxter Healthcare Corporation Corporate Summary
Table 52. Baxter Healthcare Corporation Neuropathic Pain Management Product Offerings
Table 53. Baxter Healthcare Corporation Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)
Table 54. Depomed Corporate Summary
Table 55. Depomed Neuropathic Pain Management Product Offerings
Table 56. Depomed Neuropathic Pain Management Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neuropathic Pain Management Segment by Type in 2021
Figure 2. Neuropathic Pain Management Segment by Application in 2021
Figure 3. Global Neuropathic Pain Management Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neuropathic Pain Management Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuropathic Pain Management Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuropathic Pain Management Revenue in 2021
Figure 8. By Type - Global Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 12. US Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 16. Germany Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 17. France Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 24. China Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 28. India Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 30. Brazil Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neuropathic Pain Management Revenue Market Share, 2017-2028
Figure 33. Turkey Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neuropathic Pain Management Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Services Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly and Company Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biogen Idec Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Baxter Healthcare Corporation Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Depomed Neuropathic Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)